GlassScriptPhysician profile
Daniel Ward Griepp
NPI 1134860547
$2,135.31
in general payments reported to CMS, 2019-2025
10 companies · $799 in 2025
The $799 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2023: $751 · 2024: $441 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441 · Education: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.62 |
| Education | $549.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $613.91 | 2022-2025 | Strata, Pipeline, Catalyft Pl Expandable Interbody System |
| Medical Device Business Services, INC. | $549.98 | 2024-2025 | Actis |
| Ossdsign USA Incorporated | $220.24 | 2023 | |
| Integra Lifesciences Corporation | $202.34 | 2024-2025 | Integra, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Providence Medical Technology, INC. | $144.81 | 2023 | |
| Stryker Corporation | $126.48 | 2023 | Trevo |
| Si-Bone, INC. | $123.08 | 2023 | |
| Spinal Elements, INC. | $80.17 | 2024 | |
| Depuy Synthes Sales INC. | $52.97 | 2023 | Teligen |
| Azurity Pharmaceuticals, INC. | $21.33 | 2023 | Nymalize |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Griepp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.